.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
US Department of Justice
Teva
UBS
Fish and Richardson
Cerilliant
Citi
Daiichi Sankyo
Mallinckrodt
McKesson

Generated: July 28, 2017

DrugPatentWatch Database Preview

MYAMBUTOL Drug Profile

« Back to Dashboard

Which patents cover Myambutol, and when can generic versions of Myambutol launch?

Myambutol is a drug marketed by Sti Pharma Llc and is included in one NDA.

The generic ingredient in MYAMBUTOL is ethambutol hydrochloride. There are five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ethambutol hydrochloride profile page.

Summary for Tradename: MYAMBUTOL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list8
Bulk Api Vendors: see list25
Clinical Trials: see list6
Patent Applications: see list5,244
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MYAMBUTOL at DailyMed

Pharmacology for Tradename: MYAMBUTOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sti Pharma Llc
MYAMBUTOL
ethambutol hydrochloride
TABLET;ORAL016320-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Sti Pharma Llc
MYAMBUTOL
ethambutol hydrochloride
TABLET;ORAL016320-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sti Pharma Llc
MYAMBUTOL
ethambutol hydrochloride
TABLET;ORAL016320-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sti Pharma Llc
MYAMBUTOL
ethambutol hydrochloride
TABLET;ORAL016320-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Argus Health
Deloitte
Harvard Business School
Citi
QuintilesIMS
Cerilliant
AstraZeneca
Medtronic
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot